Oster, P; Lennon, D; O'Hallahan, J; MULHOLLAND, K; Reid, S; Martin, D;
BROOKER, S; Bethony, JM; RODRIGUES, LC; ALEXANDER, N; Geiger, SM; Hotez, PJ;
°®ÍþÄÌapp review of vaccines, (2005).4 1
O'Hallahan, J; Lennon, D; Oster, P; Lane, R; Reid, S; MULHOLLAND, K; Stewart, J; Penney, L; Percival, T; Martin, D;
McIntyre, PB; Kelly, HA; MULHOLLAND, EK;
The Medical journal of Australia, (2005).182 1
Ameratunga, S; Macmillan, A; Stewart, J; Scott, D; MULHOLLAND, K; Crengle, S; Meningococcal Management Team,;
Practical aspects of phase 3 vaccine trials in developing countries.
The Grand Challenge for the Future , Birkhauser Verlag (Basel) (2005).
MANGTANI, P; Roberts, JA; Hall, AJ; Cutts, FT;
International journal of epidemiology, (2005).34 3
IgG antibodies to merozoite surface antigens are associated with recovery from chloroquine (CQ)-resistant P. falciparum in Gambian children [MIM-CS-62139].
Pinder, M; SUTHERLAND, CJ; Sisay-Joof, F; Ismaili, J; McCall, MB B; Ord, R; Hallett, R; Holder, AA; Milligan, P;
Cutts, FT; ZAMAN, SM A; Enwere, G; Jaffar, S; Levine, OS; Okoko, JB; Oluwalana, C; Vaughan, A; Obaro, SK; Leach, A; McAdam, KP; Biney, E; Saaka, M; Onwuchekwa, U; Yallop, F; Pierce, NF; GREENWOOD, BM; Adegbola, RA; Gambian Pneumococcal Vaccine Trial Group,;
ELLIOTT, AM; Namujju, PB; MAWA, PA; Quigley, MA; Nampijja, M; Nkurunziza, PM; Belisle, JT; Muwanga, M; WHITWORTH, JA G; Mother and Baby study team,;
BMC infectious diseases, (2005).5 1
